Avacta Group (LON:AVCT) Stock Crosses Above Two Hundred Day Moving Average – Should You Sell?

Avacta Group Plc (LON:AVCT)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 64.27 and traded as high as GBX 70. Avacta Group shares last traded at GBX 65, with a volume of 899,409 shares changing hands.

Avacta Group Stock Performance

The stock has a market cap of £284.46 million, a P/E ratio of -3.70 and a beta of 1.12. The stock has a fifty day simple moving average of GBX 60.34 and a 200-day simple moving average of GBX 64.27. The company has a quick ratio of 4.96, a current ratio of 0.79 and a debt-to-equity ratio of 14,168.75.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).